← Leaderboards
Klaus Klumpp
Riboscience, Llc
$5,969,109
Attributed
$5,969,109
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2017–21$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,969,109 · 2
By mechanism
R44$5,969,109 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Resistance Mutation”
- John Damon Chodera · Sloan-Kettering Inst Can Research$48,949,310
- Crystal Mackall · Children'S Hosp Of Philadelphia$15,210,841
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$12,385,742
- Gaurav Das Gaiha · Massachusetts General Hospital$8,657,852
- Thomas Dick · Rbhs-New Jersey Medical School$8,179,355
- J. Silvio Gutkind · University Of California, San Diego$7,533,097
Research focus
Resistance MutationProdrugsNucleoside AnalogResistancePharmacologyPrivate SectorDrug DevelopmentGenotoxicityDoseLeadNucleosidesPharmaceutical PreparationsChemistryAntiviral AgentsBaseClinicAdme StudyFundingClinical DevelopmentClinical ResearchIn VivoIn VitroDrug KineticsRespiratory
Grant awards (6)
Advancing a novel potent double anti-HCV nucleoside analog combination treatment for the OUD population to the clinic$995,102
R44 · FY2021 · DA · contact PI
Advancing a novel potent double anti-HCV nucleoside analog combination treatment for the OUD population to the clinic$995,102
R44 · FY2020 · DA · contact PI
Advancing a novel potent double anti-HCV nucleoside analog combination treatment for the OUD population to the clinic$995,102
R44 · FY2019 · DA · contact PI
Advancing a novel potent Zika virus specific nucleoside analog to the clinic$995,099
R44 · FY2019 · AI · contact PI
Advancing a novel potent Zika virus specific nucleoside analog to the clinic$995,099
R44 · FY2018 · AI · contact PI
Advancing a novel potent Zika virus specific nucleoside analog to the clinic$993,605
R44 · FY2017 · AI · contact PI